Karyopharm Therapeutics Inc.
H‑1B Sponsor Verified
Yes. Karyopharm Therapeutics Inc. filed 47 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2020–2026, including 3 so far in 2026. The average H-1B salary is $142,340 and the most sponsored role is Clinical Data Manager.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Mar 27, 2026.
LinkedIn ↗Latest Year Filings
3
In 2026
↗ Filter by year
Total H‑1B Filings
47
Since 2020
↗ View records
Avg Annual Salary
$142,340
All years combined
↗ View chart
Top Role
Clinical Data Manager
↗ Click to filter
Filing trend
H‑1B filings by year for Karyopharm Therapeutics Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 3 | $189,072 |
| 2025 | 9 | $138,490 |
| 2024 | 1 | $124,747 |
| 2023 | 9 | $141,410 |
| 2022 | 6 | $148,709 |
| 2021 | 7 | $169,416 |
| 2020 | 12 | $116,731 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary